It has been associated with the activation of key cancer-related signaling pathways, including EGFR, PI3K-AKT, and mTOR, as well as the downregulation of PTEN and the promotion of epithelial-mesenchymal transition (EMT) 2, 4, 5. The gene discussed is PTEN; the disease is cancer.